Article information
Full text is only available in PDF
Bibliografía
[1.]
A. Verghese, S.L. Berk.
Bacterial pneumonia in elderly.
Medicine (Baltimore), 62 (1983), pp. 271-277
[2.]
D.R. Park, S.J. Skerrett.
The usefullness of the sputum Gram stain in the diagnosis of pneumonia.
Clin Pulm Med, 2 (1995), pp. 201-212
[3.]
M. Kalin, A. Lindberg, E. Olausson.
Diagnosis of pneumococcal pneumonia by coagglutination and counterimmunoelectrophoresis of sputum samples.
Eur J Clin Microbiol, 1 (1982), pp. 91-96
[4.]
A. Torres, J. Serra-Batlles, A. Ferrer, P. Jiménez, R. Celis, E. Cobo, et al.
Severe community-acquired pneumonia: epidemiology and prognostic factors.
Am Rev Respir Dis, 144 (1991), pp. 312-318
[5.]
T.J. Marrie.
Bacteremic pneumococcal pneumonia: a continuously evolving disease.
J Infect, 242 (1992), pp. 47-55
[6.]
R. Pallares, J. Liñares, M. Vadillo, C. Cabellos, F. Manresa, P.F. Viladrich, et al.
Resistance to penicillin and cephalosporins and mortality from severe pneumococcal pneumonia in Barcelona.
N Engl J Med, 333 (1995), pp. 474-480
[7.]
G.D. Fang, M. Fine, J. Orflof, D. Arisumi, V.L. Yu, W. Kapoor, et al.
New and emerging etiologies for community acquired pneumonia with implications for therapy; a prospective multicenter study of 359 cases.
Medicine (Baltimore), 69 (1990), pp. 307-316
[8.]
M.A. Woodhead, J.T. McFarlane, J.S. McCraken, D.H. Rose, R.G. Finch.
Prospective study on the aetiology and outcome of pneumonia in the community.
Lancet, 1 (1987), pp. 671-674
[9.]
C.M. Luna, E.D. Efron, E. Schiavi, R.J. Gené, A. Famiglietti, E.C. Jolly, et al.
Neumonía adquirida en la comunidad (NAC) en adultos, guía práctica clínica para la Argentina.
Medicina (Buenos Aires), 57 (1997), pp. 343-355
[10.]
J. Almirall, I. Morató, F. Riera, A. Verdaguer, R. Priu, P. Coll, et al.
Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study.
Eur Respir J, 6 (1993), pp. 14-18
[11.]
R. Oseasohn, B.E. Skipper, B. Tempest.
Pneumonia in a Navajo community.
Am Rev Respir Dis, 117 (1978), pp. 1003-1009
[12.]
R. Austrian.
Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines.
Bethesda, MD: National Institutes of Health, (1980),
[13.]
C. Jokinen, L. Heiskanen, H. Juvonen, S. Kallinen, K. Karcola, M. Korppi, et al.
Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland.
Am J Epidemiol, 137 (1993), pp. 977-988
[14.]
J. Almirall, I. Bolíbar, J. Vidal, G. Sauca, P. Coll, B. Niklasson, et al.
Epidemiology of community-acquired pneumonia in adults: a population- based study.
Eur Respir J, 15 (2000), pp. 757-763
[15.]
B.J. Marston, J.F. Plouffe, T.M. File Jr., B.A. Hackman, S.J. Salstrom, H.B. Lipman, et al.
Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio.
Arch Intern Med, 157 (1997), pp. 1709-1718
[16.]
Pneumonia and influenza death rates – United States, 1979-1994.
Mmwr, 44 (1995), pp. 535-537
[18.]
M.J. Fine, M.A. Smith, C.A. Carson, S.S. Mutha, S.S. Sankey, L.A. Weissfeld, et al.
Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis.
Jama, 275 (1996), pp. 134-141
[19.]
R. Menéndez, J. Córdoba, P. De la Cuadra, M.J. Cremades, J.L. López- Hontagas, M. Salavert, et al.
Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.
Am J Respir Crit Care Med, 159 (1999), pp. 1868-1873
[20.]
A. Ruiz, M. Falguera, A. Nogués, M. Rubio.
Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia.
Am J Med, 106 (1999), pp. 385-390
[21.]
E. Berntsson, T. Lagergard, O. Strannegard, B. Trollfors.
Etiology of community-acquired pneumonia in outpatients.
Eur J Clin Microbiol, 5 (1986), pp. 446-447
[22.]
D.B. Langille, L. Yates, T.J. Marrie.
Serological investigation of pneumonia as it presents to the physician's office.
Can J Infect Dis, 4 (1993), pp. 328-332
[23.]
J.T. Macfarlane, A. Colville, A. Guion, R.M. MacFarlane, D.H. Rose.
Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community.
Lancet, 341 (1993), pp. 511-514
[24.]
R. Zalacaín, V. Talayero, J. Achótegui, J. Corral, I. Barreña, V. Sobradillo.
Neumonía adquirida en la comunidad. Fiabilidad de los criterios para decidir tratamiento ambulatorio.
Arch Bronconeumol, 33 (1997), pp. 74-79
[25.]
H.M. Foy, M.K. Cooney, R. McMahan, J.T. Grayston.
Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight year period.
Am J Epidemol, 97 (1973), pp. 93-102
[26.]
M. Levy, F. Dromer, N. Brion, F. Leturdu, C. Carbon.
Community acquired pneumonia.
Chest, 92 (1988), pp. 43-48
[27.]
I. Lim, D.R. Shaw, D.P. Stanley, R. Lumb, G. McLennan.
A prospective hospital study of the aetiology of community acquired pneumonia.
Med J Aust, 151 (1989), pp. 87-91
[28.]
A. Porath, F. Schlaeffer, D. Lieberman.
The epidemiology of community- acquired pneumonia among hospitalized adults.
J Infect, 34 (1997), pp. 41-48
[29.]
R. Bohte, R. Van Furth, P.J. Van den Brock.
Aetiology of community- acquired pneumonia: a prospective study among adults requiring admission to hospital.
Thorax, 50 (1995), pp. 543-547
[30.]
Research Committee of the British Thoracic Society, Public Health Laboratory Servi:ce: Community-acquired pneumonia in adults in British Hospitals in 1982-1983: A survey of aetiology, mortality, prognostic factors and outcome.
Q J Med, 62 (1987), pp. 195-220
[31.]
C.M. Luna, A. Famiglietti, R. Absi, A.J. Videla, F.J. Nogueira, A. Diaz Fuenzalida, et al.
Community-acquired pneumonia: etiology, epidemiology and outcome at a teaching hospital in Argentina.
Chest, 118 (2000), pp. 1344-1355
[32.]
J. Blanquer, R. Blanquer, R. Borrás, P. Nauffal, R. Morales, I. Menéndez, et al.
Aetiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study.
Thorax, 46 (1991), pp. 508-511
[33.]
N. Sopena, M. Sabriá-Leal, M.L. Pedro-Botet, E. Padilla, J. Domínguez, J. Morera, et al.
Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.
Chest, 113 (1998), pp. 1195-1200
[34.]
D. Lieberman, F. Schlaeffer, I. Bolden, D. Lieberman, S. Horowitz, M.G. Friedman, et al.
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
Thorax, 51 (1996), pp. 179-184
[35.]
J. Rello, E. Quintana, V. Ausina, A. Net, G. Prats.
A three-year study of severe community-acquired pneumonia with emphasis on outcome.
Chest, 103 (1993), pp. 232-235
[36.]
P. Moine, J.B. Vercken, S. Chevret, C. Chastang, P. Gajdos.
Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors.
Chest, 105 (1994), pp. 1487-1495
[37.]
M. Ruiz, S. Ewig, A. Torres, F. Arancibia, F. Marco, J. Mensa, et al.
Severe community-acquired pneumonia. Risk factors and followup epidemiology.
Am J Respir Crit Care Med, 160 (1999), pp. 923-929
[38.]
P. Olaechea, J.M. Quintana, M.S. Gallardo, J. Insausti, E. Maravi, B. Álvarez.
A predictive model for the treatment approach to community- acquired pneumonia in patients needing ICU admission.
Intensive Care Med, 22 (1996), pp. 1294-1300
[39.]
N. Hirani, J.T. MacFarlane.
Impact of management guidelines on the outcome of severe community-acquired pneumonia.
Thorax, 52 (1997), pp. 17-21
[42.]
R. Riquelme, A. Torres, M. El-Ebiary, J. Puig de la Bellacasa, R. Estruch, J. Mensa, et al.
Community-acquired pneumonia in the elderly. Clinical and nutritional aspects.
Am J Respir Crit Care Med, 156 (1997), pp. 1908-1914
[43.]
M. Ruiz, S. Ewig, M.A. Marcos, J.A. Martínez, F. Arancibia, J. Mensa, et al.
Etiology of community-acquired pneumonia: Impact of age, comorbidity and severity.
Am J Respir Crit Care Med, 160 (1999), pp. 397-405
[44.]
A. Torres, J. Dorca, R. Zalacaín, S. Bello, M. El-Ebiary, L. Molinos, et al.
Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study.
Am J Respir Crit Care Dis, 154 (1996), pp. 1456-1461
[45.]
G.M. Jong, T.R. Hsiue, C.R. Chen, H.Y. Chang, C.W. Chen.
Rapidly fatal outcome of bacteriemic Klebsiella pneumoniae pneumonia in alcoholics.
Chest, 107 (1995), pp. 214-217
[46.]
D. Steinhoff, H. Lode, G. Ruckdeschel, B. Heidrich, A. Rolfs, F.J. Fehrenbach, et al.
Chlamydia pneumoniae as a cause of community- acquired pneumonia in hospitalized patients in Berlin.
Clin Infect Dis, 22 (1996), pp. 958-964
[47.]
T.M. File, J.S. Tan.
Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia.
Curr Opin Pulm Med, 3 (1997), pp. 89-97
[48.]
R.P. Wenzel.
A new hantavirus infection in North America.
N Engl J Med, 330 (1994), pp. 1004-1005
[49.]
M.E. Lázaro, A.J. Resa, C.M. Barclay, L. Calanni, L. Samengo, P.J. Padula, et al.
Hantavirus pulmonary syndrome in Southern Argentina.
Medicina (Buenos Aires), 60 (2000), pp. 289-301
[50.]
D. Felmingham, R.N. Gruneberg.
The Alexander Project 1996- 1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
J Antimicrob Chemother, 45 (2000), pp. 191-203
[51.]
M. Guzmán-Blanco, J.M. Casellas, H.S. Sader.
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening.
Infect Dis Clin North Am, 14 (2000), pp. 67-81
[52.]
J.D. Heffelfinger, S.F. Dowell, J.H. Jorgensen, K.P. Klugman, L.R. Mabry, D.M. Musher, et al.
Management of community-acquired pneumonia in the era of pneumococcal resistan:ce: a report from the Drug-resistant Streptococcus pneumoniae. Therapeutic Working Group.
Arch Intern Med, 160 (2000), pp. 1399-1408
[53.]
R. Wise, D. Honeybourne.
Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract.
Eur Respir J, 14 (1999), pp. 221-229
[54.]
M. Miravitlles.
Moxifloxacin: an antibiotic designed for use in the community.
Eur Respir Rev, 10 (2000), pp. 161-169
[55.]
M.J. Fine, T.E. Auble, D.M. Yealy, B.A. Hanusa, L.A. Weissfeeld, D.E. Singer, et al.
A prediction rule to identify low-risk patients with community-acquired pneumonia.
N Engl J Med, 336 (1997), pp. 243-250
[56.]
B.M. Farr, A.J. Sloman, M.J. Fisch.
Predicting death in patients hospitalized for community-acquired pneumonia.
Ann Intern Med, 115 (1991), pp. 428-436
[57.]
W.A. Craig.
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
Clin Infect Dis, 26 (1998), pp. 1-12
[58.]
J.P. Nuorti, J.C. Butler, M.M. Farley, L.H. Harrison, A. McGeer, M.S. Kolczak, et al.
Cigarette smoking and invasive pneumococcal disease.
N Engl J Med, 342 (2000), pp. 681-689
[59.]
Pneumococcal vaccines.
Weekly Epidemiological Report,
Integrantes del Grupo de Trabajo ALAT: Coordinadores: C. M. Luna (Argentina) y J. Ramírez (EE.UU.) Miembros del grupo:H. López y J.A. Mazzei (Argentina); J.C. Abreu de Oliveira, J. Pereira y J.R. Jardim (Brasil); P. González y C. Lisboa (Chile); D. Maldonado y C. Torres (Colombia); S. Martínez Selmo (República Dominicana); M. Miravitlles, F. Rodríguez de Castro y A. Torres (España); A. Anzueto (EE.UU.); J.M. Luna (Guatemala); M. Díaz, R. Pérez Padilla y R. Sansores (México)
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
